OCC

ORTHOCELL LIMITED

• ASX·9h ago

  Remplir Shows Excellent Early Prostatectomy Results

• ASX·10/02 06:16

  Letter to Shareholders, Notice of AGM & Proxy Form

• ASX·10/02 01:04

  Change of Auditor

• ASX·09/20 22:56

  Orthocell Achieves First Remplir Sales in Thailand

• ASX·09/11 05:14

  Cleansing Notice-OCC.AX

• ASX·09/11 05:08

  Application for quotation of securities - OCC-OCC.AX

• ASX·09/09 22:30

  Date of AGM & Closing Date for Director Nominations-OCC.AX

• The Motley Fool·09/03 03:46

  Bell Potter says this ASX biotech could rise 56%

• Dow Jones·09/01 23:31

  *Orthocell Price Target Cut 5.0% to A$1.13/Share by Bell Potter

• ASX·08/31 02:57

  Appendix 4E & Annual Report-OCC.AX

• ASX·08/31 02:57

  Appendix 4G-OCC.AX

• ASX·08/31 02:57

  Corporate Governance Statement-OCC.AX

• ASX·08/11 22:27

  Orthocell Canaccord Genuity Conference Live Webcast-OCC.AX

• ASX·08/10 22:45

  Orthocell to Present at Canaccord Growth Conference-OCC.AX

• ASX·08/02 22:38

  Change of Registered Office & Principal Place of Business-OCC.AX